Ptc Therapeutics, Inc. · NASDAQ:PTCT

Schmertzler Michael sold 20,000 Ptc Therapeutics, Inc. shares (Form 4)

Traded Sep 9 to Sep 10, 2026 · Filed Sep 11, 2026

From Sep 9 to Sep 10, 2026, Schmertzler Michael (Director) sold 20,000 Ptc Therapeutics, Inc. shares at an average US$67.59 for US$1.35M under a trading plan, leaving 1,316,594 shares. Filed Sep 11, 2026 (Form 4).

Sold
20,000 shares
Price
US$67.59 average (US$67.34 to US$68.67)
Value
US$1.35M
Holding after
1,316,594 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 9, 2026Common StockSale9,428US$67.791,327,166Indirect
Sep 9, 2026Common StockSale572US$68.671,326,594Indirect
Sep 10, 2026Common StockSale10,000US$67.341,316,594Indirect

Source

View original at SEC

Related